Advertisement

ACA

On July 25, Centene’s CEO Sarah London detailed three key dynamics affecting the ACA risk pool this year after the company posted a $253 million loss in the second quarter. The morbidity of the ACA market in some states has…

Oscar Health is expecting to operate at a loss in 2025 as costs climb in the individual market.  The company reported preliminary results for the second quarter of 2025 on July 22, expecting a loss from operations of $200 million…

Insurers are requesting the highest ACA premium increases since 2018, according to an analysis by the Peterson-KFF Health System Tracker published July 18. Insurers are requesting a median increase of 15% based on preliminary rate filings. KFF analyzed rate increase…

Advertisement

Centene added more than 1.2 million individual members between the fourth quarter of 2024 to the first quarter of 2025, according to a report by Mark Farrah Associates.  The health plan data aggregator published an analysis of individual market enrollment…

Total risk adjustment payments in individual and small group insurance plans increased modestly in 2024, according to new data from CMS.  The agency published its annual summary report of risk adjustment payments June 18. The risk adjustment program is designed…

Centene has pulled its earnings guidance for 2025, citing higher aggregate ACA market morbidity. In a July 1 regulatory filing, Centene said it received data from consulting firm Wakely indicating overall marketplace growth in 22 of its 29 marketplace states…

Marketplace enrollment could decline between 47% and 57% if premium tax credits expire and proposed changes in Congress become law, according to an analysis from Wakely, a healthcare market research firm .  The “One Big Beautiful Bill,” a 1,000+ page…

Uncertainty around potential pharmaceutical tariffs is one factor driving up the cost of marketplace coverage in 2025, according to KFF.  Multiple insurers, including UnitedHealthcare plans in New York, Maryland and Oregon, and Independent Health have cited tariffs on pharmaceuticals as…

Advertisement